Cited in | International search | Type: | Patent literature | Publication No.: | WO2008154241
[X] (ABBOTT LAB [US], et al) [X] 1-3,5-9,11,13-17,39 * N- [5 -( 1 -benzyl-5 -cyclopropyl- IH-1 ,2,3 -triazol-4-yl)- 1 H-indazol-3 -yl]-N'-ethylurea; N-benzyl-N'-[5 -( 1 -benzyl-5 -cyclopropyl- 1 H- 1 ,2,3 -triazol-4-yl)- 1 H-indazol-3 -yl]urea; N- [5.( l -benzyl- 1 H- 1 ,2,3 -triazol-4-yl)- 1 H-indazol-3 -yl]-N'-propylurea; N-[5-(l-benzyl-lH-l,2,3-triazol-4-yl)-lH-indazol-3-yl]-N'-ethylurea;; pages 13-27; examples 260, 319, 322 *; | Type: | Patent literature | Publication No.: | WO2008156757
[X] (TAKEDA PHARMACEUTICAL [JP], et al) [X] 1,2,4,5,7,11 * Reference example 43 *; | Type: | Patent literature | Publication No.: | WO2009112275
[X] (BAYER CROPSCIENCE AG [DE], et al) [X] 1,5-8,11,13-17 * compounds 4-47, 4-60 *; | Type: | Patent literature | Publication No.: | WO2011133882
[X] (CYTOKINETICS INC [US], et al) [X] 1-3,9,11,13,14,36 * Page 188 1st compound Page 221 2nd compound *; | Type: | Patent literature | Publication No.: | WO2017189663
[X] (ENANTA PHARM INC [US]) [X] 1,4,7,12,14,36 * compounds 345-350, 354, 368-373 *; | Type: | Patent literature | Publication No.: | WO2020010155
[Y] (IFM DUE INC [US]) [Y] 1-39 * claims 1-15, 19-114, 116-170 *; | Type: | Patent literature | Publication No.: | WO2020150417
[Y] (IFM DUE INC [US]) [Y] 1-39* claims 1-26, 30-127, 136-278 * | Cited in | by applicant | Type: | Patent literature | Publication No.: | US7927613
| Type: | Patent literature | Publication No.: | US2012202848
| Type: | Patent literature | Publication No.: | WO2015061294
| Type: | Non-patent literature | Publication information: | - LAMMERS et al., "Effect of Intratumoral Injection on the Biodistribution and the Therapeutic Potential of HPMA Copolymer-Based Drug Delivery Systems", Neoplasia, (20060000), vol. 10, pages 788 - 795 | Type: | Non-patent literature | Publication information: | - FILIPSKI, K.J. et al., Current Topics in Medicinal Chemistry, (20130000), vol. 13, pages 776 - 802 |